BIOMIND LABS INC. (3XI) — Working Capital to Net Assets Ratio
BIOMIND LABS INC. (3XI) has a Working Capital to Net Assets ratio of 100.0% as of September 2025. Working capital of €-1.56 Million (current assets of €57.72K minus current liabilities of €1.62 Million) is measured against net assets of €-1.56 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of BIOMIND LABS INC. to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
BIOMIND LABS INC. Working Capital to Net Assets (2021–2024)
This chart shows how BIOMIND LABS INC.'s Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting working capital of €-1.56 Million against net assets of €-1.56 Million EUR. Check tangible net worth ratio of BIOMIND LABS INC. to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for BIOMIND LABS INC. (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for BIOMIND LABS INC. from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is BIOMIND LABS INC. worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 101.5% | €-1.32 Million | €-1.30 Million | €21.10K | €1.34 Million | ▼ -0.5 pp |
| 2023 | 102.0% | €-1.46 Million | €-1.43 Million | €45.22K | €1.51 Million | ▼ -15.8 pp |
| 2022 | 117.8% | €-291.79K | €-247.66K | €44.93K | €336.72K | ▲ +21.4 pp |
| 2021 | 96.4% | €2.11 Million | €2.19 Million | €2.44 Million | €324.69K | — |